Rhabdomyolysis, acute kidney injury, and mortality in Ebola virus disease: retrospective analysis of cases from Eastern Democratic Republic of the Congo, 2019

Kasereka Masumbuko Claude, Daniel Mukadi-Bamuleka, Richard Kitenge-Omasumbu, François Edidi-Atani, Meris Matondo Kuamfumu, Sabue Mulangu, Olivier Tshiani-Mbaya, Kambale Malengera Vicky, Placide Mbala-Kingebeni, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Bonita E Lee, Stan Houston, Zubia Mumtaz, Michael T Hawkes
{"title":"Rhabdomyolysis, acute kidney injury, and mortality in Ebola virus disease: retrospective analysis of cases from Eastern Democratic Republic of the Congo, 2019","authors":"Kasereka Masumbuko Claude, Daniel Mukadi-Bamuleka, Richard Kitenge-Omasumbu, François Edidi-Atani, Meris Matondo Kuamfumu, Sabue Mulangu, Olivier Tshiani-Mbaya, Kambale Malengera Vicky, Placide Mbala-Kingebeni, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Bonita E Lee, Stan Houston, Zubia Mumtaz, Michael T Hawkes","doi":"10.1093/infdis/jiae224","DOIUrl":null,"url":null,"abstract":"Background Skeletal muscle injury in Ebola virus disease (EVD) has been reported, but its association with morbidity and mortality remains poorly defined. Methods Retrospective study of patients admitted to two EVD Treatment Units, over an eight-month period in 2019, during a large EVD epidemic in the Democratic Republic of the Congo. Results 333 patients (median age 30 years, 58% female) had at least one creatine kinase (CK) measurement (total 2,229 CK measurements, median 5 (IQR 1-11) per patient). 271 patients (81%) had an elevated CK (>380U/L), 202 (61%) had rhabdomyolysis (CK>1,000 IU/L), and 45 (14%) had severe rhabdomyolysis (≥5,000U/L). Among survivors, the maximum CK level was median 1,600 (IQR 550 to 3,400), peaking 3.4 days after admission (IQR 2.3 to 5.5) and decreasing thereafter. Among fatal cases, the CK rose monotonically until death, with maximum CK level of median 2,900 U/L (IQR 1,500 to 4,900). Rhabdomyolysis at admission was an independent predictor of AKI (aOR 2.2 [95%CI 1.2-3.8], p=0.0065) and mortality (aHR 1.7 [95%CI 1.03-2.9], p=0.037). Conclusions Rhabdomyolysis is associated with AKI and mortality in EVD patients. These findings may inform clinical practice by identifying lab monitoring priorities and highlighting the importance of fluid management.","PeriodicalId":501010,"journal":{"name":"The Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/infdis/jiae224","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Skeletal muscle injury in Ebola virus disease (EVD) has been reported, but its association with morbidity and mortality remains poorly defined. Methods Retrospective study of patients admitted to two EVD Treatment Units, over an eight-month period in 2019, during a large EVD epidemic in the Democratic Republic of the Congo. Results 333 patients (median age 30 years, 58% female) had at least one creatine kinase (CK) measurement (total 2,229 CK measurements, median 5 (IQR 1-11) per patient). 271 patients (81%) had an elevated CK (>380U/L), 202 (61%) had rhabdomyolysis (CK>1,000 IU/L), and 45 (14%) had severe rhabdomyolysis (≥5,000U/L). Among survivors, the maximum CK level was median 1,600 (IQR 550 to 3,400), peaking 3.4 days after admission (IQR 2.3 to 5.5) and decreasing thereafter. Among fatal cases, the CK rose monotonically until death, with maximum CK level of median 2,900 U/L (IQR 1,500 to 4,900). Rhabdomyolysis at admission was an independent predictor of AKI (aOR 2.2 [95%CI 1.2-3.8], p=0.0065) and mortality (aHR 1.7 [95%CI 1.03-2.9], p=0.037). Conclusions Rhabdomyolysis is associated with AKI and mortality in EVD patients. These findings may inform clinical practice by identifying lab monitoring priorities and highlighting the importance of fluid management.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃博拉病毒病中的横纹肌溶解症、急性肾损伤和死亡率:2019年对刚果民主共和国东部病例的回顾性分析
背景 埃博拉病毒病(EVD)中的骨骼肌损伤已有报道,但其与发病率和死亡率的关系仍未明确。方法 在刚果民主共和国发生大规模埃博拉病毒疫情期间,对两个埃博拉病毒治疗单位在2019年8个月内收治的患者进行回顾性研究。结果 333 名患者(中位年龄 30 岁,58% 为女性)至少进行了一次肌酸激酶 (CK) 测量(共进行了 2,229 次 CK 测量,中位数为每名患者 5 次(IQR 1-11))。271名患者(81%)的肌酸激酶升高(>380U/L),202名患者(61%)发生横纹肌溶解(CK>1,000 IU/L),45名患者(14%)发生严重横纹肌溶解(≥5,000U/L)。在幸存者中,肌酸激酶最高水平的中位数为1,600(IQR为550至3,400),在入院后3.4天达到峰值(IQR为2.3至5.5),随后开始下降。在死亡病例中,肌酸激酶单调上升直至死亡,肌酸激酶最高水平中位数为 2,900 U/L(IQR 1,500 至 4,900)。入院时横纹肌溶解是 AKI(aOR 2.2 [95%CI 1.2-3.8],p=0.0065)和死亡率(aHR 1.7 [95%CI 1.03-2.9],p=0.037)的独立预测因素。结论 横纹肌溶解与 EVD 患者的 AKI 和死亡率有关。这些研究结果可为临床实践提供参考,确定实验室监测的重点并强调液体管理的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients with Cystic Fibrosis Rare genetic variants of NLRP12 in Admixed Latino-American Children with SARS-CoV-2-related Multisystem Inflammatory Syndrome A transgenic mouse with a humanised B cell repertoire mounts an antibody response to influenza infection and vaccination Ebola Virus Infection of Flt3-Dependent, Conventional Dendritic Cells and Antigen Cross-presentation Leads to High Levels of T-Cell Activation Changes in the lipidome are associated with immune activation and subclinical vascular disease in youth with HIV in Uganda
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1